ETF

iShares Nasdaq US Biotech ETF USD Dist

ISIN
IE00BDZVHG35

How good is this fund, really?

See the rating in the app

About iShares Nasdaq US Biotech ETF USD Dist

Only companies listed on the NASDAQ Stock Market and classed as biotechnology or pharmaceutical businesses can enter the NASDAQ Biotechnology Index, the benchmark of iShares Nasdaq US Biotech ETF USD Dist. Members must also pass NASDAQ, Inc.'s size and liquidity tests. No constituent may exceed 8% of the index, and at most five can sit at that level. The passive BlackRock fund aims to hold the index shares in similar proportions. Income is paid semi-annually in US dollars. The fund was launched in 2017 and this class in 2018, under iShares IV plc. Its ongoing charge is 0.35%, and the key investor information document assigns a risk level of 6 out of 7.

Watch this fund for free Add iShares Nasdaq US Biotech ETF USD Dist to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy iShares Nasdaq US Biotech ETF USD Dist — platforms and fees

Sold on 2 platforms we follow.

iShares Nasdaq US Biotech ETF USD Dist — its category

Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.

Biotechnology funds →

Other funds